Clorox (NYSE:CLX) Price Target Cut to $115.00 by Analysts at Rothschild & Co Redburn

Clorox (NYSE:CLX) had its target price decreased by stock analysts at Rothschild & Co Redburn from $120.00 to $115.00 in a report issued on Wednesday,MarketScreener reports. The firm currently has a “neutral” rating on the stock. Rothschild & Co Redburn’s price target points to a potential upside of 7.11% from the company’s previous close.

CLX has been the topic of several other reports. JPMorgan Chase & Co. reduced their price objective on Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday. Deutsche Bank Aktiengesellschaft dropped their price target on Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research report on Monday, October 13th. Barclays decreased their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday, September 30th. Morgan Stanley dropped their target price on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday. Finally, UBS Group set a $119.00 price target on shares of Clorox and gave the company a “neutral” rating in a report on Tuesday. One analyst has rated the stock with a Buy rating, twelve have issued a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $125.69.

Clorox Stock Up 1.0%

Shares of CLX opened at $107.37 on Wednesday. The firm has a fifty day moving average price of $119.49 and a 200-day moving average price of $124.94. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The firm has a market capitalization of $13.07 billion, a P/E ratio of 16.47, a P/E/G ratio of 0.92 and a beta of 0.52. Clorox has a 12-month low of $106.14 and a 12-month high of $171.37.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm’s revenue for the quarter was down 18.9% on a year-over-year basis. During the same quarter last year, the business posted $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities research analysts expect that Clorox will post 7.15 earnings per share for the current year.

Insider Activity

In other news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in CLX. Total Investment Management Inc. purchased a new stake in shares of Clorox during the second quarter worth about $25,000. Center for Financial Planning Inc. purchased a new position in shares of Clorox in the 3rd quarter valued at approximately $25,000. American National Bank & Trust boosted its stake in Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after purchasing an additional 89 shares in the last quarter. NewSquare Capital LLC grew its position in Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after purchasing an additional 193 shares during the last quarter. Finally, True Wealth Design LLC increased its stake in Clorox by 1,020.0% during the 3rd quarter. True Wealth Design LLC now owns 224 shares of the company’s stock valued at $28,000 after purchasing an additional 204 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.